Methylglyoxal-modified collagen promotes myofibroblast differentiation - PubMed (original) (raw)

Comparative Study

Methylglyoxal-modified collagen promotes myofibroblast differentiation

Amy Yuen et al. Matrix Biol. 2010 Jul.

Abstract

Fibrosis is a frequent complication of diabetes mellitus in many organs and tissues but the mechanism of how diabetes-induced glycation of extracellular matrix proteins impacts the formation of fibrotic lesions is not defined. As fibrosis is mediated by myofibroblasts, we investigated the effect of collagen glycation on the conversion of human cardiac fibroblasts to myofibroblasts. Collagen glycation was modeled by the glucose metabolite, methylglyoxal (MGO). Cells cultured on MGO-treated collagen exhibited increased activity of the α-smooth muscle actin promoter and enhanced expression of α-smooth muscle actin, ED-A fibronectin and cadherin, which are markers for myofibroblasts. In cells remodeling floating or stress-relaxed collagen gels, MGO treatment promoted more contraction (p<0.025) than vehicle controls, which was MGO dose-dependent. Transwell assays showed that cell migration was increased by MGO-treated collagen (p<0.025). In shear-force detachment assays, cells on MGO-treated collagen were less adherent than untreated collagen, and the formation of high affinity, β1 integrin-dependent adhesions was inhibited. MGO-collagen-induced expression of SMA was dependent on TGF-β but not on Rho kinase. We conclude that collagen glycation augments the formation and migration of myofibroblasts, critical processes in the development of fibrosis in diabetes.

PubMed Disclaimer

Cited by

Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts.
Fowlkes V, Clark J, Fix C, Law BA, Morales MO, Qiao X, Ako-Asare K, Goldsmith JG, Carver W, Murray DB, Goldsmith EC. Fowlkes V, et al. Life Sci. 2013 Mar 28;92(11):669-76. doi: 10.1016/j.lfs.2013.01.003. Epub 2013 Jan 16. Life Sci. 2013. PMID: 23333820 Free PMC article.
The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD.
Reynaert NL, Vanfleteren LEGW, Perkins TN. Reynaert NL, et al. J Clin Med. 2023 May 9;12(10):3366. doi: 10.3390/jcm12103366. J Clin Med. 2023. PMID: 37240472 Free PMC article. Review.
In situ characterization of advanced glycation end products (AGEs) in collagen and model extracellular matrix by solid state NMR.
Li R, Rajan R, Wong WCV, Reid DG, Duer MJ, Somovilla VJ, Martinez-Saez N, Bernardes GJL, Hayward R, Shanahan CM. Li R, et al. Chem Commun (Camb). 2017 Dec 14;53(100):13316-13319. doi: 10.1039/c7cc06624d. Chem Commun (Camb). 2017. PMID: 29192920 Free PMC article.
Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.
Nowotny K, Jung T, Höhn A, Weber D, Grune T. Nowotny K, et al. Biomolecules. 2015 Mar 16;5(1):194-222. doi: 10.3390/biom5010194. Biomolecules. 2015. PMID: 25786107 Free PMC article. Review.
Modulation of the Cardiovascular Risk in Type 1 Diabetic Rats by Endurance Training in Combination with the Prebiotic Xylooligosaccharide.
Choneva M, Delchev S, Hrischev P, Dimov I, Boyanov K, Dimitrov I, Gerginska F, Georgieva K, Bacelova M, Bivolarska A. Choneva M, et al. Int J Mol Sci. 2024 Sep 18;25(18):10027. doi: 10.3390/ijms251810027. Int J Mol Sci. 2024. PMID: 39337515 Free PMC article.

Methylglyoxal-modified collagen promotes myofibroblast differentiation - PubMed (original) (raw)